SCNI
Scinai Immunotherapeutics
SCNI
SCNI
9 hedge funds and large institutions have $54.7K invested in Scinai Immunotherapeutics in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
-3
Holders Change %
-25%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
1
RhumbLine Advisers
Boston,
Massachusetts
|
$3.24K |
2 |
2
Bank of America
Charlotte,
North Carolina
|
$278 |
3 |
APC
3
Aspire Private Capital
Cornelius,
North Carolina
|
$89 |
Top Sellers
1 |
AC
1
Armistice Capital
New York
|
$0 |
2 |
SM
2
Sabby Management
Miami Beach,
Florida
|
$49.6K |
3 |
3
Citadel Advisors
Miami,
Florida
|
$0 |
4 |
4
Millennium Management
New York
|
$0 |
5 |
5
Morgan Stanley
New York
|
$709 |